Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
3.150
-0.170 (-5.12%)
At close: Dec 27, 2024, 4:00 PM
3.170
+0.020 (0.63%)
After-hours: Dec 27, 2024, 7:59 PM EST
Lipella Pharmaceuticals Stock Forecast
LIPO's stock price has decreased by -59.41% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for LIPO stock has a target of 16, which predicts an increase of 407.94% from the current stock price of 3.15.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 9, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for LIPO is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 |
---|---|---|
Strong Buy | 1 | 1 |
Buy | 0 | 0 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +407.94% | Apr 9, 2024 |
Financial Forecast
Revenue This Year
370.26K
from 449.62K
Decreased by -17.65%
Revenue Next Year
n/a
from 370.26K
EPS This Year
-8.01
from -6.16
EPS Next Year
-5.30
from -8.01
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 381,150 | n/a | n/a |
Avg | 370,260 | n/a | n/a |
Low | 355,740 | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | -15.2% | - | - |
Avg | -17.6% | - | - |
Low | -20.9% | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -8.24 | -5.46 | -18.29 |
Avg | -8.01 | -5.30 | -17.77 |
Low | -7.69 | -5.10 | -17.07 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.